S100 calcium binding protein A9 (S100-A9) antibody and antigen (Recombinant protein)
Diagnostic S100 calcium binding protein A9 (S100-A9) antibodies (anti-S100 calcium binding protein A9, anti-S100-A9) and antigens (recombinant S100 calcium binding protein A9 (S100-A9) protein) for Inflammation/autoimmune/inflammatory disease S100-A9 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-S100-A9-Ag01 | Recombinant human S100A9/S100-A9/CAGB/CFAG Protein | 3090 |
GMP-h-S100-A9-Ab01 | Anti-human S100A9/S100-A9/CAGB/CFAG mouse monoclonal antibody (mAb) | 1953 |
GMP-h-S100-A9-Ab02 | Anti-human S100A9/S100-A9/CAGB/CFAG mouse monoclonal antibody (mAb) | 1953 |
GMP-h-S100-A9-Ab03 | Anti-human S100A9/S100-A9/CAGB/CFAG human monoclonal antibody (mAb) | 1953 |
GMP-h-S100-A9-Ab04 | Anti-human S100A9/S100-A9/CAGB/CFAG human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-S100-A9-Ag01 |
Product Name | Recombinant human S100A9/S100-A9/CAGB/CFAG Protein |
Target/Biomarker | S100 calcium binding protein A9 (S100-A9) |
Alias of Target/Biomarker | 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG, MAC387, MIF, MRP14, NIF, P14, S100-A9 |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | S100 calcium binding protein A9 (S100-A9) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in S100-A9 level test of Inflammation/autoimmune/inflammatory disease (inflammatory bowel disease) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human S100A9/S100-A9/CAGB/CFAG Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-S100-A9-Ab01, GMP-h-S100-A9-Ab02 |
Product Name | Anti-human S100A9/S100-A9/CAGB/CFAG mouse monoclonal antibody (mAb) |
Target/Biomarker | S100 calcium binding protein A9 (S100-A9) |
Alias of Target/Biomarker | 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG, MAC387, MIF, MRP14, NIF, P14, S100-A9 |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | S100 calcium binding protein A9 (S100-A9) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in S100-A9 level test of Inflammation/autoimmune/inflammatory disease (inflammatory bowel disease) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human S100A9/S100-A9/CAGB/CFAG mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-S100-A9-Ab03, GMP-h-S100-A9-Ab04 |
Product Name | Anti-human S100A9/S100-A9/CAGB/CFAG human monoclonal antibody (mAb) |
Target/Biomarker | S100 calcium binding protein A9 (S100-A9) |
Alias of Target/Biomarker | 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG, MAC387, MIF, MRP14, NIF, P14, S100-A9 |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | S100 calcium binding protein A9 (S100-A9) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in S100-A9 level test of Inflammation/autoimmune/inflammatory disease (inflammatory bowel disease) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human S100A9/S100-A9/CAGB/CFAG human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Calprotectin is a protein released by a type of white blood cell called a neutrophil. When there is inflammation in the gastrointestinal (GI) tract, neutrophils move to the area and release calprotectin, resulting in an increased level in the stool. Intestinal inflammation is associated with inflammatory bowel disease (IBD) and with some bacterial GI infections, but it is not associated with many other disorders that affect bowel function and cause similar symptoms. Calprotectin can be used to help distinguish between inflammatory and non-inflammatory conditions.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments